Rayner is a British medical device manufacturer specializing in intraocular lenses (IOLs) and surgical solutions for cataract and refractive surgery. Their flagship product, the RayOne Fully Preloaded IOL Injection System, features patented Lock & Roll technology, which allows for the smallest incision during implantation, enhancing patient comfort and recovery. Additionally, Rayner has expanded its offerings in the U.S. market through the acquisition of OMIDRIA, a drug used during cataract surgery to maintain pupil dilation and reduce postoperative pain. This strategic move underscores Rayner's commitment to providing comprehensive surgical solutions.

The company also emphasizes the importance of clinical education and patient engagement through its digital platforms. RayPRO is a free mobile and web-based platform that collects Patient Reported Outcomes (PROs) over three years, providing valuable insights into patient experiences. Furthermore, Rayner's Eye Science program is dedicated to robust clinical training and product support, ensuring that healthcare professionals are well-equipped to utilize their innovative technologies effectively. With over 70 years of experience, Rayner continues to lead in the field of ophthalmic devices, focusing on quality and patient satisfaction.

United Kingdom

Rayner manufactured the world's first IOL in 1949, and has remained at the forefront of innovation for over 70 years, focused on providing you and your patients with the best IOLs and ophthalmic solutions - always driven by science to improve patient outcomes and safety.

Rayner is the only manufacturer of IOLs in the UK, with its state-of-the-art manufacturing plant and Global Headquarters on the South Coast of England.

Rayner is a fast-paced and growing business with 500+ employees worldwide.

Rayner

Company Details